#chmp — Public Fediverse posts

https://www.europesays.com/at/307714/ S1P-Signalweg bremst Thrombosen im Mausmodell ohne erhöhtes Blutungsrisiko #AI #Antikoagulation #ARTIFICIALINTELLIGENCE #AT #Austria #Bluthochdruck #Blutung #Cha2ds2Vasc #Cha2ds2VascScore #Chmp #EMA #Endothel #Gesundheit #Health #KI #KünstlicheIntelligenz #Leitlinien #Lerodalcibep #Obicetrapib #Österreich #S1p #S1pRezeptor #Smartphone #Thrombomodulin #Thromboseprävention #Vorhofflimmern

https://www.europesays.com/at/302464/ Bluthochdruck: Kombinationspräparate senken Abbruchrisiko um 39% #AceInhibitor #Adherence #AI #ARTIFICIALINTELLIGENCE #AT #Austria #BetaBlocker #BfArM #CalciumChannelBlocker #Chmp #Combination #Dosage #Drug #economics #FDA #Gesundheit #Health #Hypertension #KI #KünstlicheIntelligenz #Österreich #Pharmacy #Recall #Regulation #Sartan #Shortage #supply #therapy #Thiazide

https://www.europesays.com/uk/1118008/ Two breast cancer therapies, Enhertu and Etcamah, advance through EU regulatory process #CHMP #DESTINYBreast09 #EU #Europe #European #SERENA6

Two breast cancer therapies, Enhertu and Etcamah, advance through EU regulatory process

Two significant regulatory developments signal progress in expanding treatment options for breast cancer patients in the European Union,…
#Europe #EU #CHMP #DESTINY-Breast09 #EuropeanUnion #SERENA-6
https://www.europesays.com/europe/104920/

Two breast cancer therapies, Enhertu and Etcamah, advance through EU regulatory process

Two significant regulatory developments signal progress in expanding treatment options for breast cancer patients in the European Union,…
#EuropeSays #Britain #Europe #EU #AstraZeneca #CHMP #DESTINY-Breast09 #SERENA-6
https://www.europesays.com/britain/92856/

https://www.europesays.com/britain/92856/ Two breast cancer therapies, Enhertu and Etcamah, advance through EU regulatory process #AstraZeneca #CHMP #DESTINYBreast09 #SERENA6

https://www.europesays.com/it/602215/ Psoriasi, la pillola che blocca l’IL-23 potrebbe riscrivere le regole della cura #AgenziaEuropeaPerIMedicinali #CHMP #CommissioneEuropea #Health #icotrokinra #Interleuchina23 #IT #Italia #Italy #PASI90 #psoriasi #Salute #TerapiaOrale #UnioneEuropea

https://www.europesays.com/ch/107608/ CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD) #(nAMD) #AgeRelated #Approval #CHMP #continuous #degeneration #delivery #EU #first #for #macular #neovascular #of #recommends #Roche #Roche’s #Susvimo #the #treatment

https://www.europesays.com/at/267106/ GLP-1 gegen Diabetes: Geruchsstörungen steigen laut Studie deutlich #AT #Austria #Chmp #Diabetes #EliLilly #EMA #Geruchsstörung #Geschmacksstörung #Gesundheit #Gewichtverlust #GLP1 #Health #Implantat #Liraglutid #Mounjaro #Nebenwirkungen #Oral #Österreich #Semaglutid

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

Recommendation follows an Article 20 non-pharmacovigilance procedure Patients currently on TAVNEOS treatment should consult their treating physician  ST. GALLEN, Switzerland,…
#Europe #EU #authorisation #avacopan #CHMP #European #EuropeanUnion #for #in #marketing #recommends #revoking #TAVNEOS #the #Union
https://www.europesays.com/europe/80144/

CHMP recommends EU revocation of TAVNEOS

Recommendation follows an Article 20 non-pharmacovigilance procedure Patients currently on TAVNEOS treatment should consult their treating physician   ST. GALLEN,…
#Europe #EU #ANCA-associatedvasculitis #avacopan #CHMP #CSL #CSLLY #EMA #European #EuropeanCommission #TAVNEOS
https://www.europesays.com/europe/80132/

Lilly’s Jaypirca wins EU review for CLL

The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, previously…
#Europe #EU #EuropeanCommission #CHMP #CLL #EliLilly #EuropeanUnion #Jaypirca #LLY #oncology #pirtobrutinib
https://www.europesays.com/europe/80059/

Acadia DAYBU wins EU approval recommendation

Key Terms

committee for medicinal products for human use

regulatory
…
#Europe #EU #EuropeanCommission #ACAD #Acadia #CHMP #DAYBU #EuropeanUnion #Rettsyndrome #trofinetide
https://www.europesays.com/europe/80003/

https://www.europesays.com/dk/90414/ Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class #A/S #Approval #as #by #CHMP #Class #efficacious #EU #First #for #GLP1 #in #Its #most #Nordisk #novo #NovoNordisk #Obesity #Oral #pill #Recommended #representing #semaglutide #the #Treatment #Wegovy

https://www.europesays.com/dk/90147/ Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1) #1 #207% #72 #A #A/S #Approval #CHMP #EU #in #Loss #mean #mg #Nordisk #novo #NovoNordisk #of #pen #providing #recommends #SingleDose #to #Up #Wegovy #Weight

https://www.europesays.com/dk/89995/ Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® #Approval #CHMP #CopenhagenStockExchange:NOVOB #EMA #InjectableWegovy #NovoNordisk #NovoNordiskA/S #Obesity #PositiveOpinion #SingleDoseDevise #STEPUp #Wegovy72Mg #WegovyHighDose #Wegovy®HD

Novo Nordisk A/S: CHMP recommends EU approval of Wegovy®

Wegovy® 7.2 mg in a single-dose pen has now been recommended by CHMP for approval in the EUNovo…
#Europe #EU #approval #CHMP #CopenhagenStockExchange:NOVOB #EMA #EuropeanUnion #injectablewegovy #NovoNordiskA/S #Obesity #positiveopinion #single-dosedevise #STEPup #Wegovy7.2mg #wegovyHD #wegovyHighDose
https://www.europesays.com/europe/50499/

Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU

Pratteln, Switzerland, April 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announced that the Committee for Medicinal Products…
#Europe #EU #EuropeanCommission #(vamorolone) #AGAMREE® #Aged #and #CHMP #DMD #Expand #in #Older #Opinion #Patients #pediatric #Positive #receives #Santhera #the #to #Two #use
https://www.europesays.com/europe/23653/

https://www.europesays.com/es/395574/ El CHMP respalda la aprobación de pegunigalsidasa alfa en la enfermedad de Fabry #administración #adoptado #alfa #ampliacion #aprobacion #basa #bright #cada #chmp #comite #Cuatro #datos #decisión #enfermedad #ES #España #Estudio #fabry #farmacocinéticos #ha #Health #humano #integrados #Medicamentos #Opinión #pegunigalsidasa #positiva #posológica #respalda #resultados #Salud #semanas #Spain #uso

Patients protest against possible withdrawal of rare liver disease medicine https://www.euractiv.com/section/health-consumers/news/patients-protest-against-possible-withdrawal-of-rare-liver-disease-medicine/?utm_source=dlvr.it&utm_medium=mastodon #CHMP #EASL #EMA #EuropeanMedicinesAgency #liver

Patients protest against possible withdrawal of rare liver disease medicine https://www.euractiv.com/section/health-consumers/news/patients-protest-against-possible-withdrawal-of-rare-liver-disease-medicine/?utm_source=dlvr.it&utm_medium=mastodon #CHMP #EASL #EMA #EuropeanMedicinesAgency #liver

Patients protest against possible withdrawal of rare liver disease medicine https://www.euractiv.com/section/health-consumers/news/patients-protest-against-possible-withdrawal-of-rare-liver-disease-medicine/?utm_source=dlvr.it&utm_medium=mastodon #CHMP #EASL #EMA #EuropeanMedicinesAgency #liver

R to @EMA_News: The 1st gene editing therapy to treat #SickleCellDisease & #BetaThalassemia recommended for approval by EMA's human medicines committee, is also the 1st medicine using a novel gene-editing technology (#CRISPR/Cas9) in the 🇪🇺.

➡️ https://www.ema.europa.eu/en/news/first-gene-editing-therapy-treat-beta-thalassemia-and-severe-sickle-cell-disease

#CHMP #PublicHealth

🐦🔗: https://nitter.cz/EMA_News/status/1735660082413592605#m

[2023-12-15 13:56 UTC]

R to @EMA_News: The 1st gene editing therapy to treat #SickleCellDisease & #BetaThalassemia recommended for approval by EMA's human medicines committee, is also the 1st medicine using a novel gene-editing technology (#CRISPR/Cas9) in the 🇪🇺.

➡️ https://www.ema.europa.eu/en/news/first-gene-editing-therapy-treat-beta-thalassemia-and-severe-sickle-cell-disease

#CHMP #PublicHealth

🐦🔗: https://nitter.cz/EMA_News/status/1735660082413592605#m

[2023-12-15 13:56 UTC]

Today’s authorisation by the European Medicines Agency is an important step ahead of winter so that people can increase their protection against RSV.
I encourage Member States to make it available to citizens quickly, especially the most vulnerable.
<div class="rsshub-quote">
EU Medicines Agency: 📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10
</div>

🐦🔗: https://n.respublicae.eu/SKyriakidesEU/status/1682382166439673857

Today’s authorisation by the European Medicines Agency is an important step ahead of winter so that people can increase their protection against RSV.
I encourage Member States to make it available to citizens quickly, especially the most vulnerable.
<div class="rsshub-quote">
EU Medicines Agency: 📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10
</div>

🐦🔗: https://n.respublicae.eu/SKyriakidesEU/status/1682382166439673857

📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10

🐦🔗: https://n.respublicae.eu/EMA_News/status/1682364425775325184

📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10

🐦🔗: https://n.respublicae.eu/EMA_News/status/1682364425775325184

📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10

🐦🔗: https://n.respublicae.eu/EMA_News/status/1682364425775325184

The agenda of EMA's human #medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-17-20-july-2023_en.pdf

🐦🔗: https://n.respublicae.eu/EMA_News/status/1680843262297341956

The agenda of EMA's human #medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-17-20-july-2023_en.pdf

🐦🔗: https://n.respublicae.eu/EMA_News/status/1680843262297341956

RT EU Medicines Agency
The agenda of EMA's human medicines committee #CHMP is now published. 💊💉
Find out what medicines will be discussed this month: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-19-22-june-2023_en.pdf
The committee highlights will be released on Friday.

🐦🔗: https://n.respublicae.eu/EMA_News/status/1670740308567416837

RT EU Medicines Agency
The agenda of EMA's human medicines committee #CHMP is now published. 💊💉
Find out what medicines will be discussed this month: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-19-22-june-2023_en.pdf
The committee highlights will be released on Friday.

🐦🔗: https://n.respublicae.eu/EMA_News/status/1670740308567416837

RT EU Medicines Agency
The agenda of EMA's human medicines committee #CHMP is now published. 💊💉
Find out what medicines will be discussed this month: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-19-22-june-2023_en.pdf
The committee highlights will be released on Friday.

🐦🔗: https://n.respublicae.eu/EMA_News/status/1670740308567416837

RT EU Medicines Agency
📢EMA's human medicines committee, the #CHMP, recommended 2⃣ new medicines for approval in the 🇪🇺, including:
☑️ one medicine for the prophylaxis of #migraine
☑️ one medicine for the treatment of chronic #KidneyDisease
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-19-22-june-2023
#PublicHealth https://t.co/MmoBuogHs2

🐦🔗: https://n.respublicae.eu/EMA_News/status/1672221581534195712

RT EU Medicines Agency
📢EMA's human medicines committee, the #CHMP, recommended 2⃣ new medicines for approval in the 🇪🇺, including:
☑️ one medicine for the prophylaxis of #migraine
☑️ one medicine for the treatment of chronic #KidneyDisease
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-19-22-june-2023
#PublicHealth https://t.co/MmoBuogHs2

🐦🔗: https://n.respublicae.eu/EMA_News/status/1672221581534195712

📢EMA's human medicines committee, the #CHMP, recommended 2 new medicines 💊for approval in the 🇪🇺, including:
☑️ one medicine to diagnose prostate #cancer
☑️ one medicine for the treatment of #epilepsy
#publichealth 👇https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-may-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1662075982381998081

📢EMA's human medicines committee, the #CHMP, recommended 2 new medicines 💊for approval in the 🇪🇺, including:
☑️ one medicine to diagnose prostate #cancer
☑️ one medicine for the treatment of #epilepsy
#publichealth 👇https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-may-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1662075982381998081

The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉 👇
The committee highlights will be released on Friday.

https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-22-25-may-2023_en.pdf

🐦🔗: https://n.respublicae.eu/EMA_News/status/1660574487530598400

The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉 👇
The committee highlights will be released on Friday.

https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-22-25-may-2023_en.pdf

🐦🔗: https://n.respublicae.eu/EMA_News/status/1660574487530598400

📢EMA's human medicines committee, the #CHMP, recommended 7 new medicines for approval in the 🇪🇺, including:
☑️ one vaccine for Respiratory Syncytial Virus #RSV
☑️ three medicines for #cancer
☑️ one medicine for a rare disease #Pompe

#publichealth

👉 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-24-26-april-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1651265157538930689

📢EMA's human medicines committee, the #CHMP, recommended 7 new medicines for approval in the 🇪🇺, including:
☑️ one vaccine for Respiratory Syncytial Virus #RSV
☑️ three medicines for #cancer
☑️ one medicine for a rare disease #Pompe

#publichealth

👉 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-24-26-april-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1651265157538930689

📢EMA's human medicines committee, the #CHMP, recommended 7 new medicines for approval in the 🇪🇺, including:
☑️ one vaccine for Respiratory Syncytial Virus #RSV
☑️ three medicines for #cancer
☑️ one medicine for a rare disease #Pompe

#publichealth

👉 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-24-26-april-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1651265157538930689

The agenda of EMA's human medicines committee #CHMP is now published.

Find out what medicines will be discussed this month 💊💉

The committee highlights will be released on Wednesday.

https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-24-26-april-2023_en.pdf

🐦🔗: https://n.respublicae.eu/EMA_News/status/1650434887843819520

The agenda of EMA's human medicines committee #CHMP is now published.

Find out what medicines will be discussed this month 💊💉

The committee highlights will be released on Wednesday.

https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-24-26-april-2023_en.pdf

🐦🔗: https://n.respublicae.eu/EMA_News/status/1650434887843819520

📢EMA's human medicines committee, the #CHMP, recommended 9⃣ new medicines for approval in the 🇪🇺, including:
☑️ one #COVID19vaccine
☑️ one medicine for #MultipleSclerosis
☑️ one medicine for #Epilepsy

➡️https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-march-2023

#PublicHealth

🐦🔗: https://n.respublicae.eu/EMA_News/status/1641782170711740416

📢EMA's human medicines committee, the #CHMP, recommended 9⃣ new medicines for approval in the 🇪🇺, including:
☑️ one #COVID19vaccine
☑️ one medicine for #MultipleSclerosis
☑️ one medicine for #Epilepsy

➡️https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-march-2023

#PublicHealth

🐦🔗: https://n.respublicae.eu/EMA_News/status/1641782170711740416

The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-27-30-march-2023_en.pdf

🐦🔗: https://n.respublicae.eu/EMA_News/status/1640308612072370180

The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-27-30-march-2023_en.pdf

🐦🔗: https://n.respublicae.eu/EMA_News/status/1640308612072370180

📢EMA's human medicines committee, the #CHMP, recommended 8⃣ new #medicines for approval in the 🇪🇺 including:
☑️ three medicines for #cancer
☑️ one medicine for #Fabry disease
☑️ one medicine for facial #angiofibroma
#PublicHealth 👇
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-february-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1629085367843401732

📢EMA's human medicines committee, the #CHMP, recommended 8⃣ new #medicines for approval in the 🇪🇺 including:
☑️ three medicines for #cancer
☑️ one medicine for #Fabry disease
☑️ one medicine for facial #angiofibroma
#PublicHealth 👇
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-february-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1629085367843401732

The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-23-26-february-2023_en.pdf

🐦🔗: https://n.respublicae.eu/EMA_News/status/1627646407543848960

The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-23-26-february-2023_en.pdf

🐦🔗: https://n.respublicae.eu/EMA_News/status/1627646407543848960

📢EMA's human medicines committee, the #CHMP, recommended 4⃣ new medicines for approval in the 🇪🇺, including:
☑️ one medicine for plaque #psoriasis
☑️ two treatments for #diabetes type 2

#PublicHealth

👉 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-23-26-january-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1618933495983935492

📢EMA's human medicines committee, the #CHMP, recommended 4⃣ new medicines for approval in the 🇪🇺, including:
☑️ one medicine for plaque #psoriasis
☑️ two treatments for #diabetes type 2

#PublicHealth

👉 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-23-26-january-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1618933495983935492

The agenda of EMA's human medicines committee #CHMP is now published.

Find out what medicines will be discussed this month 💊💉: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-23-26-january-2023_en.pdf

The committee highlights will be released on Friday.

🐦🔗: https://n.respublicae.eu/EMA_News/status/1617483638635114496

The agenda of EMA's human medicines committee #CHMP is now published.

Find out what medicines will be discussed this month 💊💉: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-23-26-january-2023_en.pdf

The committee highlights will be released on Friday.

🐦🔗: https://n.respublicae.eu/EMA_News/status/1617483638635114496

The #CHMP also recommended to extend the use of #COVID19 vaccine #Spikevax 💉as a booster in children aged 6 to 11 years. ⬇️

#VaccinesWork

https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-december-2022

🐦🔗: https://n.respublicae.eu/EMA_News/status/1603711320376983556

The #CHMP also recommended to extend the use of #COVID19 vaccine #Spikevax 💉as a booster in children aged 6 to 11 years. ⬇️

#VaccinesWork

https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-december-2022

🐦🔗: https://n.respublicae.eu/EMA_News/status/1603711320376983556

The #CHMP recommended for authorisation the 1⃣st gene therapy to treat #haemophilia B in adults ⬇️

https://www.ema.europa.eu/en/news/first-gene-therapy-treat-haemophilia-b

🐦🔗: https://n.respublicae.eu/EMA_News/status/1603711318233649152